Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Partial failure of CPAP treatment for sleep apnoea: Analysis of the French national sleep database.

Bailly S, Daabek N, Jullian-Desayes I, Joyeux-Faure M, Sapène M, Grillet Y, Borel JC, Tamisier R, Pépin JL.

Respirology. 2019 Jul 23. doi: 10.1111/resp.13650. [Epub ahead of print]

PMID:
31336407
2.

Liver Fibrosis, Sleep Apnea and Cardiovascular Events in Stroke Patients.

Viglino D, Baillieul S, Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Pépin JL.

Cerebrovasc Dis. 2019;47(5-6):309-310. doi: 10.1159/000501259. Epub 2019 Jun 19. No abstract available.

3.

Diagnosis and management of central sleep apnea syndrome.

Baillieul S, Revol B, Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Pépin JL.

Expert Rev Respir Med. 2019 Jun;13(6):545-557. doi: 10.1080/17476348.2019.1604226. Epub 2019 Apr 24.

PMID:
31014146
4.

Long-term adherence to ambulatory initiated continuous positive airway pressure in non-syndromic OSA children.

Perriol MP, Jullian-Desayes I, Joyeux-Faure M, Bailly S, Andrieux A, Ellaffi M, Jounieaux F, Pépin JL, Lamblin C.

Sleep Breath. 2019 Jun;23(2):575-578. doi: 10.1007/s11325-018-01775-2. Epub 2019 Jan 26.

PMID:
30685850
5.

Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database.

Revol B, Jullian-Desayes I, Cracowski JL, Tamisier R, Mallaret M, Joyeux-Faure M, Pepin JL.

Sleep. 2019 Feb 1;42(2). doi: 10.1093/sleep/zsy242. No abstract available.

PMID:
30590830
6.

Multimodal Remote Monitoring of High Cardiovascular Risk Patients With OSA Initiating CPAP: A Randomized Trial.

Pépin JL, Jullian-Desayes I, Sapène M, Treptow E, Joyeux-Faure M, Benmerad M, Bailly S, Grillet Y, Stach B, Richard P, Lévy P, Muir JF, Tamisier R.

Chest. 2019 Apr;155(4):730-739. doi: 10.1016/j.chest.2018.11.007. Epub 2018 Nov 22.

PMID:
30472022
7.

Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease.

Viglino D, Plazanet A, Bailly S, Benmerad M, Jullian-Desayes I, Tamisier R, Leroy V, Zarski JP, Maignan M, Joyeux-Faure M, Pépin JL.

Sci Rep. 2018 Nov 8;8(1):16559. doi: 10.1038/s41598-018-34988-2.

8.

What is the best treatment strategy for obstructive sleep apnoea-related hypertension?

Revol B, Jullian-Desayes I, Bailly S, Regnaut L, Tamisier R, Pepin JL, Joyeux-Faure M.

Hypertens Res. 2018 Dec;41(12):1070-1072. doi: 10.1038/s41440-018-0114-5. Epub 2018 Oct 15. No abstract available.

PMID:
30323261
9.

Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data.

Joyeux-Faure M, Tamisier R, Borel JC, Millasseau S, Galerneau LM, Destors M, Bailly S, Pepin JL.

Thorax. 2018 Dec;73(12):1146-1151. doi: 10.1136/thoraxjnl-2018-211513. Epub 2018 Jul 21.

PMID:
30032122
10.

Continuous Positive Airway Pressure Reduces Night-Time Blood Pressure and Heart Rate in Patients With Obstructive Sleep Apnea and Resistant Hypertension: The RHOOSAS Randomized Controlled Trial.

Joyeux-Faure M, Baguet JP, Barone-Rochette G, Faure P, Sosner P, Mounier-Vehier C, Lévy P, Tamisier R, Pépin JL.

Front Neurol. 2018 May 8;9:318. doi: 10.3389/fneur.2018.00318. eCollection 2018.

11.

Ticagrelor and Central Sleep Apnea.

Revol B, Jullian-Desayes I, Tamisier R, Puel V, Mallaret M, Joyeux-Faure M, Pépin JL.

J Am Coll Cardiol. 2018 May 22;71(20):2378-2379. doi: 10.1016/j.jacc.2018.03.447. No abstract available.

12.

Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database.

Revol B, Jullian-Desayes I, Bailly S, Mallaret M, Tamisier R, Agier MS, Lador F, Joyeux-Faure M, Pépin JL.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701855. doi: 10.1183/13993003.01855-2017. Print 2018 Jan. No abstract available.

13.

Drugs and obstructive sleep apnoea.

Revol B, Jullian-Desayes I, Pepin JL, Joyeux-Faure M.

Br J Clin Pharmacol. 2017 Oct;83(10):2317-2318. doi: 10.1111/bcp.13361. Epub 2017 Jul 14. No abstract available.

14.

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

Viglino D, Jullian-Desayes I, Minoves M, Aron-Wisnewsky J, Leroy V, Zarski JP, Tamisier R, Joyeux-Faure M, Pépin JL.

Eur Respir J. 2017 Jun 8;49(6). pii: 1601923. doi: 10.1183/13993003.01923-2016. Print 2017 Jun.

15.

Prevalence of obesity hypoventilation syndrome in ambulatory obese patients attending pathology laboratories.

Borel JC, Guerber F, Jullian-Desayes I, Joyeux-Faure M, Arnol N, Taleux N, Tamisier R, Pépin JL.

Respirology. 2017 Aug;22(6):1190-1198. doi: 10.1111/resp.13051. Epub 2017 Apr 11.

PMID:
28397994
16.

Acquired central hypoventilation following Listeria monocytogenes rhombencephalitis.

Launois SH, Siyanko N, Joyeux-Faure M, Tamisier R, Pepin JL.

Thorax. 2017 Aug;72(8):763-765. doi: 10.1136/thoraxjnl-2016-208786. Epub 2017 Jan 13. No abstract available.

PMID:
28087753
17.

Severe excessive daytime sleepiness induced by hydroxyurea.

Revol B, Joyeux-Faure M, Albahary MV, Gressin R, Mallaret M, Pepin JL, Launois SH.

Fundam Clin Pharmacol. 2017 Jun;31(3):367-368. doi: 10.1111/fcp.12260. Epub 2017 Jan 24.

PMID:
27998000
18.

Continuous positive airway pressure treatment impact on memory processes in obstructive sleep apnea patients: a randomized sham-controlled trial.

Joyeux-Faure M, Naegelé B, Pépin JL, Tamisier R, Lévy P, Launois SH.

Sleep Med. 2016 Aug;24:44-50. doi: 10.1016/j.sleep.2016.06.023. Epub 2016 Aug 23.

PMID:
27810185
19.

Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.

Briançon-Marjollet A, Monneret D, Henri M, Joyeux-Faure M, Totoson P, Cachot S, Faure P, Godin-Ribuot D.

Exp Physiol. 2016 Nov 1;101(11):1432-1442. doi: 10.1113/EP085783. Epub 2016 Oct 5.

20.

Impact of concomitant medications on obstructive sleep apnoea.

Jullian-Desayes I, Revol B, Chareyre E, Camus P, Villier C, Borel JC, Pepin JL, Joyeux-Faure M.

Br J Clin Pharmacol. 2017 Apr;83(4):688-708. doi: 10.1111/bcp.13153. Epub 2016 Nov 24. Review.

21.

Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy: A Case Series.

Olivier PY, Joyeux-Faure M, Gentina T, Launois SH, d'Ortho MP, Pépin JL, Gagnadoux F.

Chest. 2016 May;149(5):e127-31. doi: 10.1016/j.chest.2015.10.001.

PMID:
27157226
22.

Drugs influencing acid base balance and bicarbonate concentration readings.

Jullian-Desayes I, Borel JC, Guerber F, Borel AL, Tamisier R, Levy P, Schwebel C, Pepin JL, Joyeux-Faure M.

Expert Rev Endocrinol Metab. 2016 Mar;11(2):209-216. doi: 10.1586/17446651.2016.1147951. Epub 2016 Feb 24.

PMID:
30058869
23.

Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.

Joyeux-Faure M, Jullian-Desayes I, Pepin JL, Cracowski JL, Baguet JP, Tamisier R, Levy P, Godin-Ribuot D, Launois SH.

Respirology. 2016 Apr;21(3):546-52. doi: 10.1111/resp.12713. Epub 2015 Dec 8.

24.

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Jullian-Desayes I, Tamisier R, Zarski JP, Aron-Wisnewsky J, Launois-Rollinat SH, Trocme C, Levy P, Joyeux-Faure M, Pepin JL.

Respirology. 2016 Feb;21(2):378-85. doi: 10.1111/resp.12672. Epub 2015 Nov 16.

25.

Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.

Joyeux-Faure M, Tamisier R, Baguet JP, Dias-Domingos S, Perrig S, Leftheriotis G, Janssens JP, Trzepizur W, Launois SH, Stanke-Labesque F, Lévy PA, Gagnadoux F, Pepin JL.

Mediators Inflamm. 2014;2014:423120. doi: 10.1155/2014/423120. Epub 2014 Aug 25.

26.

Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.

Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Launois S, Borel AL, Levy P, Pepin JL.

Sleep Med Rev. 2015 Jun;21:23-38. doi: 10.1016/j.smrv.2014.07.004. Epub 2014 Jul 31. Review.

PMID:
25220580
27.

Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia.

Totoson P, Fhayli W, Faury G, Korichneva I, Cachot S, Baldazza M, Ribuot C, Pépin JL, Lévy P, Joyeux-Faure M.

Exp Biol Med (Maywood). 2013 Feb;238(2):223-32. doi: 10.1177/1535370212473696. Epub 2013 Feb 12.

PMID:
23404941
28.

Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia.

Ramond A, Godin-Ribuot D, Ribuot C, Totoson P, Koritchneva I, Cachot S, Levy P, Joyeux-Faure M.

Fundam Clin Pharmacol. 2013 Jun;27(3):252-61. doi: 10.1111/j.1472-8206.2011.01015.x. Epub 2011 Dec 7.

PMID:
22145601
29.

Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study.

Joyeux-Faure M, Durand M, Bedague D, Protar D, Incagnoli P, Paris A, Ribuot C, Levy P, Chavanon O.

Fundam Clin Pharmacol. 2012 Dec;26(6):761-70. doi: 10.1111/j.1472-8206.2011.00992.x. Epub 2011 Sep 20.

PMID:
21929528
30.

Erythropoietin improved initial resuscitation and increased survival after cardiac arrest in rats.

Incagnoli P, Ramond A, Joyeux-Faure M, Pépin JL, Lévy P, Ribuot C.

Resuscitation. 2009 Jun;80(6):696-700. doi: 10.1016/j.resuscitation.2009.03.024. Epub 2009 Apr 29.

PMID:
19406554
31.

Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.

Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D.

J Am Coll Cardiol. 2009 Apr 14;53(15):1309-17. doi: 10.1016/j.jacc.2008.12.050.

32.

Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts.

Ramond A, Sartorius E, Mousseau M, Ribuot C, Joyeux-Faure M.

Exp Biol Med (Maywood). 2008 Jan;233(1):76-83.

PMID:
18156309
33.

Cellular protection by erythropoietin: new therapeutic implications?

Joyeux-Faure M.

J Pharmacol Exp Ther. 2007 Dec;323(3):759-62. Epub 2007 Aug 23. Review.

PMID:
17717190
34.

Comparison of the effects of zinc alone and zinc associated with selenium and vitamin E on insulin sensitivity and oxidative stress in high-fructose-fed rats.

Faure P, Barclay D, Joyeux-Faure M, Halimi S.

J Trace Elem Med Biol. 2007;21(2):113-9. Epub 2007 Mar 6.

PMID:
17499151
35.

Deleterious myocardial consequences induced by intermittent hypoxia are reversed by erythropoietin.

Ramond A, Ribuot C, Lévy P, Joyeux-Faure M.

Respir Physiol Neurobiol. 2007 Jun 15;156(3):362-9. Epub 2006 Dec 11.

PMID:
17161979
36.

Fructose-fed rat hearts are protected against ischemia-reperfusion injury.

Joyeux-Faure M, Rossini E, Ribuot C, Faure P.

Exp Biol Med (Maywood). 2006 Apr;231(4):456-62.

PMID:
16565441
37.

Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.

Joyeux-Faure M, Ramond A, Béguin PC, Belaïdi E, Godin-Ribuot D, Ribuot C.

Fundam Clin Pharmacol. 2006 Feb;20(1):51-6.

PMID:
16448394
38.
39.

Erythropoietin and myocardial protection: what's new?

Joyeux-Faure M, Godin-Ribuot D, Ribuot C.

Fundam Clin Pharmacol. 2005 Aug;19(4):439-46. Review.

PMID:
16011730
40.

Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat.

Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, Caron F, Bessard G, Lévy P, Stanke-Labesque F.

Respir Physiol Neurobiol. 2006 Feb 28;150(2-3):278-86. Epub 2005 Jun 24.

PMID:
15979951
41.

Acute intermittent hypoxia improves rat myocardium tolerance to ischemia.

Béguin PC, Joyeux-Faure M, Godin-Ribuot D, Lévy P, Ribuot C.

J Appl Physiol (1985). 2005 Sep;99(3):1064-9. Epub 2005 May 5.

42.

Chronic intermittent hypoxia increases infarction in the isolated rat heart.

Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Béguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, Lévy P.

J Appl Physiol (1985). 2005 May;98(5):1691-6. Epub 2004 Dec 23.

43.
44.

Heat stress preconditioning and delayed myocardial protection: what is new?

Joyeux-Faure M, Arnaud C, Godin-Ribuot D, Ribuot C.

Cardiovasc Res. 2003 Dec 1;60(3):469-77. Review.

PMID:
14659792
45.

COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.

Arnaud C, Joyeux-Faure M, Godin-Ribuot D, Ribuot C.

Cardiovasc Res. 2003 Jun 1;58(3):582-8.

PMID:
12798431

Supplemental Content

Loading ...
Support Center